College of Pharmacy research theme

Drug design, development, and delivery

Research affiliations


Research Summary

Nanomedicine is a multidisciplinary branch of science that currently receives a lot of attention from researchers in the pharmaceutical and biomedical fields. The Labouta Lab is using state-of-the-art nanotechnologies and microfluidic lab-on-a-chip models for designing and evaluating nanoparticles (engineered particles on the nanometer scale). The use of nanoparticles in drug delivery offers several advantages, such as site-specific targeting, minimal side-effects, prolonged drug release, and improved drug stability and bioavailability.

Key research areas of the Labouta lab:


Dr. Hagar Labouta is an Assistant Professor at the College of Pharmacy, with extensive research experience in nanomedicine, drug delivery, and biomedical engineering. Her lab is well-funded by New Frontiers in Research Fund, NSERC and the University of Manitoba.  

Dr. Labouta has a strong publication record and is a co-inventor on an international patent for the development of carrier systems for intracellular drug targeting.

Throughout her career, she has collaborated with several multi-disciplinary teams in Canada, Germany, Switzerland, Australia, USA, Egypt and Finland. She has also worked with the World Health Organization on two health-related projects.



ORCID profile

Visit Hagar Labouta's ORCID profile for a complete listing.

Hagar Labouta's profile

Contact us

College of Pharmacy
Apotex Centre
750 McDermot Ave W
University of Manitoba (Bannatyne campus)
Winnipeg, MB R3E 0T5 Canada